dolutegravir - Robuta Search

https://adisinsight.springer.com/drugsafety/803926956?error=cookies_not_supported&code=02012cd7-cd60-4690-afd0-a83d156c90a9 Tenofovir disoproxil fumarate/Lamivudine/Dolutegravir - AdisInsight Among 40 HIV-positive patients [*ages and sexes not stated*] treated with tenofovir disoproxil fumarate, lamivudine and dolutegravir, 22 experienced a tenofovir disoproxil fumarate lamivudine dolutegravir adisinsight https://boris-portal.unibe.ch/entities/publication/790882fa-3c4e-4c42-b45a-e40fd8ca0bc3 Disparities in Dolutegravir Uptake Affecting Females of Reproductive Age With HIV in Low- and... BACKGROUND The transition to dolutegravir-containing antiretroviral therapy (ART) in low- and middle-income countries (LMICs) was complicated by an initial... https://bibliographie.uni-tuebingen.de/xmlui/handle/10900/86076?show=full Enhanced Eryptosis Following Exposure to Dolutegravir enhanced following exposure dolutegravir https://myhealth.alberta.ca/Health/medications/Pages/conditions.aspx?hwid=fdb1636 Abacavir/Dolutegravir/Lamivudine - Oral abacavir dolutegravir lamivudine oral https://adisinsight.springer.com/drugsafety/803322990?error=cookies_not_supported&code=abdbb4c9-a76e-455f-bdda-f8880ceef91d Dolutegravir/phenobarbital interaction - AdisInsight A 41-year-old man showed decreased plasma concentration of dolutegravir following concomitant administration of dolutegravir and phenobarbital [routes not dolutegravir phenobarbital interaction adisinsight https://publikationen.uni-tuebingen.de/xmlui/handle/10900/86076?show=full Enhanced Eryptosis Following Exposure to Dolutegravir enhanced following exposure dolutegravir https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=63df5af3-b8ac-4e76-9830-2dbb340af922&audience=professional DailyMed - TIVICAY PD- dolutegravir sodium tablet, for suspension TIVICAY- dolutegravir sodium... dailymed pd dolutegravir sodium tablet https://www.jnj.com/media-center/press-releases/janssen-announces-submissions-in-europe-and-us-for-single-tablet-regimen-of-dolutegravir-plus-rilpivirine-the-first-two-drug-hiv-maintenance-treatment Janssen Announces Submissions in Europe and US for Single- Tablet Regimen of Dolutegravir plus... Jul 18, 2025 - - Two-drug regimen could offer many patients the option to switch to a regimen that does not include a nucleotide reverse transcriptase inhibitor - https://adisinsight.springer.com/drugsafety/803540234?error=cookies_not_supported&code=3b656774-b74b-4ffe-9491-f58eb3f2913a Abacavir/dolutegravir/lamivudine/calcium-carbonate/vitamins interaction - AdisInsight A 35-year-old woman showed viral load increased following concomitant administration of abacavir/dolutegravir/lamivudine, unspecified vitamins and calcium calcium carbonate abacavir dolutegravir lamivudine vitamins https://adisinsight.springer.com/drugsafety/803273829?error=cookies_not_supported&code=948e1433-c627-4b99-b790-47b1e4eba188 Dolutegravir/elvitegravir/raltegravir - AdisInsight In an observational single-centre study, three patients [1 woman and 2 men; exact ages not stated] were described who developed resistance to raltegravir and dolutegravir elvitegravir raltegravir adisinsight https://pubmed.ncbi.nlm.nih.gov/33010240/ Dolutegravir with emtricitabine and tenofovir alafenamide or tenofovir disoproxil fumarate versus... USAID, Unitaid, South African Medical Research Council, ViiV Healthcare. tenofovir alafenamide dolutegravir emtricitabine fumarate versus https://adisinsight.springer.com/trials/700248203?error=cookies_not_supported&code=26f02b9a-e42b-417f-9e51-f6cc9a69869e A Randomised Trial of Dolutegravir (DTG)-Based Antiretroviral Therapy vs. Standard of Care (SOC) in... This phase 2/3 study is evaluating dolutegravir (DTG)-based antiretroviral therapy (ART) versus standard-of-care in HIV-infected children starting first- or https://pubmed.ncbi.nlm.nih.gov/37930812/ Proportion of APOBEC3-induced defective HIV DNA after 1 year of dolutegravir + lamivudine... Whereas no significant change in the proportion of patients with APOBEC3-defective proviruses was evidenced after 1 year of dolutegravir + lamivudine... https://www.mdpi.com/2077-0383/12/24/7759 Dolutegravir/Lamivudine versus Tenofovir Alafenamide/Emtricitabine/Bictegravir as a Switch Strategy... Background: The aim of the study is to evaluate the effectiveness, safety, and tolerability of a two-drug regimen (2-DR) dolutegravir/lamivudine (DTG/3TC)... tenofovir alafenamide dolutegravir lamivudine versus https://adisinsight.springer.com/drugsafety/803914410?error=cookies_not_supported&code=90069ffa-f11a-4d27-834e-0a193a677262 Dolutegravir - AdisInsight An elderly man developed persistent insomnia during treatment with dolutegravir for HIV. The man started receiving dolutegravir-based antiretroviral therapy. He dolutegravir adisinsight https://chembl.blogspot.com/2013/09/new-drug-approvals-2013-pt-xiii.html New Drug Approvals 2013 - Pt. XIII - Dolutegravir (TivicaysupTM/sup) ATC code: J05AX12 On 12 August, the FDA approved a further drug for the treatment of HIV-1 infection, Dolutegravir (Tradename: T... new drug approvals pt xiii dolutegravir sup https://myhealth.alberta.ca/health/medications/Pages/conditions.aspx?hwid=fdb1895 Dolutegravir/Rilpivirine - Oral dolutegravir oral https://www.semanticscholar.org/topic/dolutegravir/199126 dolutegravir | Semantic Scholar An orally bioavailable integrase strand-transfer inhibitor (INSTI), with activity against human immunodeficiency virus type 1 (HIV-1) infection. Upon oral... dolutegravir semantic scholar https://pubmed.ncbi.nlm.nih.gov/40751346/ Effectiveness of dolutegravir based antiretroviral treatment in preventing vertical transmission of... BackgroundSeveral antiretroviral regimens have been used for prevention of mother to child transmission (MTCT) of HIV, with maternal dolutegravir-based... effectiveness dolutegravir based antiretroviral treatment https://adisinsight.springer.com/drugsafety/803923035?error=cookies_not_supported&code=68a113fd-d3ae-4a62-a8bb-991476af0773 Dolutegravir - AdisInsight Adults living with HIV in Central Uganda who received dolutegravir-based antiretroviral therapy for at least one year were found to experience hyperglycaemia as dolutegravir adisinsight https://adisinsight.springer.com/drugsafety/803892360?error=cookies_not_supported&code=eaeee4a5-837c-4cb2-a619-dee5cd0e52a9 Dolutegravir/lamivudine/tenofovir - AdisInsight A 38-year-old man developed peripheral neuropathy during treatment with dolutegravir/lamivudine/tenofovir for HIV infection.* The man was diagnosed with HIV dolutegravir lamivudine tenofovir adisinsight